Winston Pharmaceuticals (Winston Pharmaceuticals) Total Assets : $0.84 Mil (As of Mar. 2010)

View and export this data going back to 2006. Start your Free Trial

What is Winston Pharmaceuticals Total Assets?

Winston Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2010 was $0.84 Mil.

Total Assets is connected with ROA %. Winston Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2010 was -146.47%. Total Assets is also linked to Revenue through Asset Turnover. Winston Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2010 was 0.25.

Winston Pharmaceuticals Total Assets Historical Data

The historical data trend for Winston Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Pharmaceuticals Total Assets Chart

Winston Pharmaceuticals Annual Data

Trend

Sep05

Sep06

Sep07

Dec08

Dec09

Total Assets

0.01

4.59

5.79

1.68

Winston Pharmaceuticals Quarterly Data
	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10
Total Assets	Get a 7-Day Free Trial														4.31	3.33	2.45	1.68	0.84

Winston Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Winston Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2009 is calculated as

Total Assets	=	Total Equity (A: Dec. 2009 )	+	Total Liabilities (A: Dec. 2009 )
	=	0.489	+	1.187
	=	1.68

Winston Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2010 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2010 )	+	Total Liabilities (Q: Mar. 2010 )
	=	0.065	+	0.777
	=	0.84

Winston Pharmaceuticals (GREY:WPHM) Total Assets Explanation

Total Assets is connected with ROA %.

Winston Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2010 is

ROA %	=	Net Income (Q: Mar. 2010 )	/	( (Total Assets (Q: Dec. 2009 )	+	Total Assets (Q: Mar. 2010 ))	/ count )
	=	-1.844	/	( (1.676	+	0.842)	/ 2 )
	=	-1.844	/	1.259
	=	-146.47 %

Note: The Net Income data used here is four times the quarterly (Mar. 2010) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Winston Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2010 is

	Asset Turnover
=	Revenue (Q: Mar. 2010 )	/	( (Total Assets (Q: Dec. 2009 )	+	Total Assets (Q: Mar. 2010 ))	/ count )
=	0.317	/	( (1.676	+	0.842)	/ 2 )
=	0.317	/	1.259
=	0.25

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Winston Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Winston Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Winston Pharmaceuticals (Winston Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Pharmaceuticals Inc (GREY:WPHM) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 North Fairway Drive, Suite 134, Vernon Hills, IL, USA, 60061

Website

http://www.winstonlabs.com

Winston Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the discovery and development of products for pain management. The company focuses on major pain indications such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease.

Executives

Frost Phillip Md Et Al	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Frost Gamma Investments Trust	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137
Subbarao V Uppaluri	director	4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137
Curtis Lockshin	director	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Glenn L Halpryn	director	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Steven Jerry Glauser	10 percent owner	1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Noah M Silver	director, officer: Vice President	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Alan Jay Weisberg	director, officer: Chief Financial Officer	2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Stephen Bittel	10 percent owner	4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137

Winston Pharmaceuticals (Winston Pharmaceuticals) Headlines

No Headlines